Bone morphogenic protein

Journal of Neurosurgery: Spine

Volumn 9, Issue 4, 2008, Pages 401-

  Dickerman, Rob D ^a   Reynolds, Ashley ^a   Tackett, Jennifer ^a   Morgan, Brent ^a   Bennett, Matthew ^a  

^a TEXAS BACK INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE CEMENT; BONE MORPHOGENETIC PROTEIN; HYDROXYAPATITE; KETONE DERIVATIVE; POLYETHERETHERKETONE; UNCLASSIFIED DRUG; BIOMATERIAL; KETONE; MACROGOL DERIVATIVE;

ALLOGRAFT; CERVICAL DISCECTOMY; CERVICAL SPINE; DISEASE SEVERITY; DRUG DELIVERY SYSTEM; DYSPHAGIA; HUMAN; INTERVERTEBRAL DISKECTOMY; LETTER; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; POSTOPERATIVE PERIOD; SAFETY; SPINE FUSION; SURGICAL ANATOMY; SURGICAL APPROACH; SURGICAL SPONGE; DOSE RESPONSE; INSTRUMENTATION; INTERNAL FIXATOR; METHODOLOGY; NOTE;

BIOCOMPATIBLE MATERIALS; BONE MORPHOGENETIC PROTEINS; CERVICAL VERTEBRAE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INTERNAL FIXATORS; KETONES; POLYETHYLENE GLYCOLS; SPINAL FUSION;

EID: 85047684100     PISSN: 15475654     EISSN: 15475646     Source Type: Journal    
DOI: 10.3171/SPI.2008.9.10.401     Document Type: Letter

References (3)

1. Bennett M, Reynolds AS, Dickerman RD: Recent article by Shields et al: "Adverse effects associated with high-dose recombinant human bone morphogenic protein-2 use in anterior cervical spine fusion. Spine 31:2029-2030, 2006
2. Dickerman RD, Reynolds AS, Morgan B: Polyetheretherketone (PEEK) cage filled with bone morphogenic protein and demineralised bone matrix in anterior cervical discectomy and fusion. Int Orthop 28:3-4, 2007
3. Dickerman RD, Reynolds AS, Morgan BC, Tompkins J, Cattorini J, Bennett M: Rh-BMP-2 can be used safely in the cervical spine: dose and containment are the keys! Spine J 7:508-509, 2007 (Pubitemid 47040676)